SCHEMBL1384547

SCHEMBL1384547

CN(C)CCCn1cc(-c2ccccc2)c(OCc2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.42
HRH3 Q9Y5N1 2/20 0.41
KDM4E B2RXH2 2/20 0.41
KCNH2 Q12809 2/20 0.41
GUCY1B2 O75343 1/20 0.41
CYP1A2 P05177 1/20 0.41
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CYP2D6 P10635 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD1 P21728 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
GUCY1A2 P33402 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRM1 P35372 1/20 0.41
DRD3 P35462 1/20 0.41
SLC6A3 Q01959 1/20 0.41
GUCY1A1 Q02108 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2575915 0.99 POLB (0.42) PDE10AHRH3KDM4EKCNH2GUCY1B2
Oxalic Acid SCHEMBL2577871 0.94 KDM4E (0.48) PDE10AHRH3KDM4EKCNH2GUCY1B2
SCHEMBL1385049 0.94 PDE10A (0.43) PDE10AHRH3KDM4EKCNH2GUCY1B2
Hydrochloric Acid SCHEMBL2577843 0.93 PDE10A (0.42) PDE10AHRH3KDM4EKCNH2GUCY1B2
SCHEMBL1387082 0.86 PDE10A (0.41) PDE10AHRH3KDM4EKCNH2GUCY1B2
SCHEMBL1386510 0.86 AURKA (0.39) PDE10AHRH3KDM4EKCNH2GUCY1B2
SCHEMBL1386167 0.85 PTGS2 (0.43) PDE10AHRH3KDM4EKCNH2GUCY1B2
SCHEMBL1386845 0.84 PDE10A (0.41) PDE10AKCNH2CYP1A2CHRM2HTR1A
Oxalic Acid SCHEMBL6419992 0.83 KDM4E (0.41) HRH3KDM4ECYP2D6POLBLTA4H
SCHEMBL1386325 0.83 GABRG2 (0.42) PDE10AKDM4EHTR1ASQORHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4833078-B2 2011-12-07 JP claimed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP claimed
WO-2005051917-A9 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2005-09-29 WO claimed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO claimed
EP-1689720-B1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2009-04-15 EP disclosed
EP-1689720-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS Aventis Pharma S.A. (FR) 2006-08-16 EP disclosed
WO-2005051917-A9 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2005-09-29 WO disclosed
WO-2005051917-A1 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA S.A. (FR) 2005-06-09 WO disclosed